Symbol:
1700017B05Rik
Name:
RIKEN cDNA 1700017B05 gene
Description:
Predicted to localize to the cytosol. Orthologous to human C15orf39 (chromosome 15 open reading frame 39); INTERACTS WITH (+)-schisandrin B (ortholog); (-)-demecolcine (ortholog); (-)-epigallocatechin 3-gallate (ortholog).
Type:
protein-coding
RefSeq Status:
VALIDATED
Also known as:
AA682102; D9Ertd278e; hypothetical protein LOC74211; MGC144191; uncharacterized protein C15orf39 homolog
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
C15orf39 (chromosome 15 open reading frame 39) HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
RGD1305464 (similar to human chromosome 15 open reading frame 39) HGNC
Treefam, EggNOG, NCBI, OMA, HomoloGene, Inparanoid, Panther, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
LOC102003077 (chromosome unknown open reading frame, human C15orf39) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
C15H15orf39 (chromosome 15 C15orf39 homolog) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
C30H15orf39 (chromosome 30 C15orf39 homolog) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
CUNH15orf39 (chromosome unknown C15orf39 homolog) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
C7H15orf39 (chromosome 7 C15orf39 homolog) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Rattus norvegicus (Norway rat):
RGD1305464 (similar to human chromosome 15 open reading frame 39)
Alliance
DIOPT (OrthoFinder, PANTHER)
Homo sapiens (human):
C15orf39 (chromosome 15 open reading frame 39)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Danio rerio (zebrafish):
si:dkey-73n10.1
Alliance
DIOPT (Ensembl Compara, InParanoid, OrthoInspector, PANTHER, ZFIN)
Latest Assembly:
GRCm38 - Mouse Genome Assembly GRCm38
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm38 9 57,252,322 - 57,262,599 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 MGSCv37 9 57,100,129 - 57,110,406 (-) NCBI GRCm37 mm9 NCBIm37 MGSCv36 9 57,780,149 - 57,791,618 (-) NCBI mm8 MGSCv36 9 57,049,280 - 57,060,749 (-) NCBI mm8 Celera 9 54,488,043 - 54,498,371 (-) NCBI Celera Cytogenetic Map 9 B NCBI cM Map 9 30.89 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
(+)-schisandrin B multiple interactions ISO RGD:1305464 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RGD1305464 mRNA] CTD PMID:31150632 (-)-demecolcine decreases expression ISO RGD:1604333 6480464 Demecolcine results in decreased expression of C15ORF39 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1604333 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of C15ORF39 mRNA CTD PMID:22079256 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1305464 6480464 Tetrachlorodibenzodioxin results in increased expression of RGD1305464 mRNA CTD PMID:21215274 2-hydroxypropanoic acid increases expression ISO RGD:1604333 6480464 Lactic Acid results in increased expression of C15ORF39 mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1604333 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of C15ORF39 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of C15ORF39 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1604333 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of C15ORF39 mRNA CTD PMID:28628672 aflatoxin B1 increases methylation ISO RGD:1604333 6480464 Aflatoxin B1 results in increased methylation of C15ORF39 gene, Aflatoxin B1 results in increased methylation of C15ORF39 intron CTD PMID:27153756 , PMID:30157460 aflatoxin B2 increases methylation ISO RGD:1604333 6480464 aflatoxin B2 results in increased methylation of C15ORF39 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1305464 6480464 Tretinoin results in increased expression of RGD1305464 mRNA CTD PMID:20488242 arsane affects methylation ISO RGD:1604333 6480464 Arsenic affects the methylation of C15ORF39 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1604333 6480464 Arsenic affects the methylation of C15ORF39 gene CTD PMID:25304211 benzo[a]pyrene affects methylation ISO RGD:1604333 6480464 Benzo(a)pyrene affects the methylation of C15ORF39 intron CTD PMID:30157460 benzo[e]pyrene increases methylation ISO RGD:1604333 6480464 benzo(e)pyrene results in increased methylation of C15ORF39 intron CTD PMID:30157460 bisphenol A affects expression ISO RGD:1305464 6480464 bisphenol A affects the expression of C15ORF39 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:1604333 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of C15ORF39 mRNA CTD PMID:28628672 cisplatin decreases expression ISO RGD:1604333 6480464 Cisplatin results in decreased expression of C15ORF39 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:1604333 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of C15ORF39 mRNA CTD PMID:27392435 copper atom multiple interactions ISO RGD:1604333 6480464 [NSC 689534 binds to Copper] which results in decreased expression of C15ORF39 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1604333 6480464 [NSC 689534 binds to Copper] which results in decreased expression of C15ORF39 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1604333 6480464 Copper Sulfate results in decreased expression of C15ORF39 mRNA CTD PMID:19549813 dexamethasone multiple interactions ISO RGD:1604333 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of C15ORF39 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of C15ORF39 mRNA CTD PMID:28628672 dicrotophos increases expression ISO RGD:1604333 6480464 dicrotophos results in increased expression of C15ORF39 mRNA CTD PMID:28302478 diuron increases expression ISO RGD:1305464 6480464 Diuron results in increased expression of RGD1305464 mRNA CTD PMID:25152437 doxorubicin decreases expression ISO RGD:1604333 6480464 Doxorubicin results in decreased expression of C15ORF39 mRNA CTD PMID:29803840 ethyl methanesulfonate decreases expression ISO RGD:1604333 6480464 Ethyl Methanesulfonate results in decreased expression of C15ORF39 mRNA CTD PMID:23649840 flutamide increases expression ISO RGD:1305464 6480464 Flutamide results in increased expression of RGD1305464 mRNA CTD PMID:24136188 formaldehyde decreases expression ISO RGD:1604333 6480464 Formaldehyde results in decreased expression of C15ORF39 mRNA CTD PMID:23649840 gamma-hexachlorocyclohexane decreases expression ISO RGD:1604333 6480464 Hexachlorocyclohexane results in decreased expression of C15ORF39 mRNA CTD PMID:24356939 glycidol increases expression ISO RGD:1305464 6480464 glycidol results in increased expression of RGD1305464 mRNA CTD PMID:24915197 indometacin multiple interactions ISO RGD:1604333 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of C15ORF39 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of C15ORF39 mRNA CTD PMID:28628672 menadione affects expression ISO RGD:1604333 6480464 Vitamin K 3 affects the expression of C15ORF39 mRNA CTD PMID:20044591 methapyrilene increases methylation ISO RGD:1604333 6480464 Methapyrilene results in increased methylation of C15ORF39 intron CTD PMID:30157460 methyl methanesulfonate decreases expression ISO RGD:1604333 6480464 Methyl Methanesulfonate results in decreased expression of C15ORF39 mRNA CTD PMID:23649840 ochratoxin A decreases expression ISO RGD:1604333 6480464 ochratoxin A metabolite results in decreased expression of C15ORF39 mRNA, ochratoxin A results in decreased expression of C15ORF39 mRNA CTD PMID:24356939 orphenadrine affects expression ISO RGD:1305464 6480464 Orphenadrine affects the expression of RGD1305464 mRNA CTD PMID:23665939 paracetamol increases expression ISO RGD:1604333 6480464 Acetaminophen results in increased expression of C15ORF39 mRNA CTD PMID:21420995 , PMID:29067470 potassium chromate increases expression ISO RGD:1604333 6480464 potassium chromate(VI) results in increased expression of C15ORF39 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1604333 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of C15ORF39 mRNA CTD PMID:22079256 rac-lactic acid increases expression ISO RGD:1604333 6480464 Lactic Acid results in increased expression of C15ORF39 mRNA CTD PMID:30851411 rotenone decreases expression ISO RGD:1604333 6480464 Rotenone results in decreased expression of C15ORF39 mRNA CTD PMID:29955902 silicon dioxide increases expression ISO RGD:1604333 6480464 Silicon Dioxide results in increased expression of C15ORF39 mRNA CTD PMID:25351596 tetrachloromethane increases expression ISO RGD:1305464 6480464 Carbon Tetrachloride results in increased expression of RGD1305464 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:1305464 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RGD1305464 mRNA] CTD PMID:31150632 thioacetamide increases expression ISO RGD:1305464 6480464 Thioacetamide results in increased expression of RGD1305464 mRNA CTD PMID:23411599 urethane increases expression ISO RGD:1604333 6480464 Urethane results in increased expression of C15ORF39 mRNA CTD PMID:28818685 valdecoxib increases expression ISO RGD:1305464 6480464 valdecoxib results in increased expression of RGD1305464 mRNA CTD PMID:24136188 valproic acid increases methylation ISO RGD:1604333 6480464 Valproic Acid results in increased methylation of C15ORF39 gene CTD PMID:29154799 vinclozolin decreases expression ISO RGD:1305464 6480464 vinclozolin results in decreased expression of RGD1305464 mRNA CTD PMID:23034163 vincristine decreases expression ISO RGD:1604333 6480464 Vincristine results in decreased expression of C15ORF39 mRNA CTD PMID:23649840 zinc atom multiple interactions ISO RGD:1604333 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of C15ORF39 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1604333 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of C15ORF39 mRNA CTD PMID:18593933 
Gene-Chemical Interaction Annotations
